Gabriela R Oates1, William T Harris1, Hector H Gutierrez1, Cathy Mims2, Sarah B Rutland1, Corilyn Ott3, Soumya J Niranjan4, Isabel C Scarinci5, Susan C Walley6. 1. Pediatric Pulmonary and Sleep Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 2. Children's of Alabama, Birmingham, Alabama. 3. Birmingham Veterans Affairs Medical Center, Birmingham, Alabama. 4. Department of Health Services Administration, School of Health Professions, University of Alabama at Birmingham, Birmingham, Alabama. 5. Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama. 6. Pediatric Hospital Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
Abstract
OBJECTIVE: Tobacco smoke exposure has negative impacts on the lung health of children with cystic fibrosis (CF), yet evidence-based strategies for smoking cessation have not been tested with or tailored to CF caregivers. This qualitative study identified barriers and facilitators of smoking cessation in this population and outlined potential interventional approaches. METHODS: We conducted semi-structured interviews with CF familial caregivers who were current or former smokers, and with members of the CF care team. We asked about experiences, practices, and prerequisites for a successful program. Interviews were recorded, transcribed verbatim, and coded by two investigators. Analysis used a thematic approach guided by the PRECEDE model, which identifies predisposing (intrapersonal), reinforcing (interpersonal), and enabling (structural) factors relevant to health behaviors and programs. RESULTS: Seventeen interviews were conducted-eight with familial caregivers and nine with CF team members. Whereas caregivers provided greater insight into internal difficulties and motivators to quit smoking, clinicians offered more extensive input on barriers and solutions related to the clinical environment. Based on study recommendations, a successful tobacco cessation program should include (a) family education about the harms of smoke exposure for children with CF; (b) screening for exposure, ideally with biochemical verification; (c) access to trained tobacco counselors; (d) affordable pharmacotherapy; and (e) outpatient follow-up of those undergoing tobacco treatment. CONCLUSION: This qualitative study revealed intrapersonal, interpersonal, and structural barriers to eliminating tobacco smoke exposure in children with CF, outlined opportunities to address these barriers, and made recommendations for a comprehensive tobacco cessation strategy.
OBJECTIVE:Tobacco smoke exposure has negative impacts on the lung health of children with cystic fibrosis (CF), yet evidence-based strategies for smoking cessation have not been tested with or tailored to CF caregivers. This qualitative study identified barriers and facilitators of smoking cessation in this population and outlined potential interventional approaches. METHODS: We conducted semi-structured interviews with CF familial caregivers who were current or former smokers, and with members of the CF care team. We asked about experiences, practices, and prerequisites for a successful program. Interviews were recorded, transcribed verbatim, and coded by two investigators. Analysis used a thematic approach guided by the PRECEDE model, which identifies predisposing (intrapersonal), reinforcing (interpersonal), and enabling (structural) factors relevant to health behaviors and programs. RESULTS: Seventeen interviews were conducted-eight with familial caregivers and nine with CF team members. Whereas caregivers provided greater insight into internal difficulties and motivators to quit smoking, clinicians offered more extensive input on barriers and solutions related to the clinical environment. Based on study recommendations, a successful tobacco cessation program should include (a) family education about the harms of smoke exposure for children with CF; (b) screening for exposure, ideally with biochemical verification; (c) access to trained tobacco counselors; (d) affordable pharmacotherapy; and (e) outpatient follow-up of those undergoing tobacco treatment. CONCLUSION: This qualitative study revealed intrapersonal, interpersonal, and structural barriers to eliminating tobacco smoke exposure in children with CF, outlined opportunities to address these barriers, and made recommendations for a comprehensive tobacco cessation strategy.
Authors: Alice Little Caldwell; Martha S Tingen; Joshua T Nguyen; Jeannette O Andrews; Janie Heath; Jennifer L Waller; Frank A Treiber Journal: Pediatrics Date: 2018-01 Impact factor: 7.124
Authors: Don B Sanders; Julia Emerson; Clement L Ren; Michael S Schechter; Ronald L Gibson; Wayne Morgan; Margaret Rosenfeld Journal: Ann Am Thorac Soc Date: 2015-08
Authors: Georg E Matt; Penelope J E Quintana; Joy M Zakarian; Eunha Hoh; Melbourne F Hovell; Melinda Mahabee-Gittens; Kayo Watanabe; Kathy Datuin; Cher Vue; Dale A Chatfield Journal: Tob Control Date: 2016-09-21 Impact factor: 7.552
Authors: Drucy Borowitz; Karen A Robinson; Margaret Rosenfeld; Stephanie D Davis; Kathryn A Sabadosa; Stephanie L Spear; Suzanne H Michel; Richard B Parad; Terry B White; Philip M Farrell; Bruce C Marshall; Frank J Accurso Journal: J Pediatr Date: 2009-12 Impact factor: 4.406
Authors: Benjamin T Kopp; Rohan Thompson; Jeeho Kim; Robert Konstan; Alejandro Diaz; Bennett Smith; Chandra Shrestha; Lynette K Rogers; Don Hayes; Dmitry Tumin; Frederick W Woodley; Octavio Ramilo; Don B Sanders; Judith A Groner; Asuncion Mejias Journal: Thorax Date: 2019-01-19 Impact factor: 9.139
Authors: G E Matt; P J E Quintana; M F Hovell; J T Bernert; S Song; N Novianti; T Juarez; J Floro; C Gehrman; M Garcia; S Larson Journal: Tob Control Date: 2004-03 Impact factor: 7.552
Authors: Gabriela R Oates; Elizabeth Baker; Joseph M Collaco; Steven M Rowe; Sarah B Rutland; Christopher M Fowler; William T Harris Journal: J Cyst Fibros Date: 2021-07-17 Impact factor: 5.527